Correction to: Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma

J Exp Clin Cancer Res. 2021 Jun 2;40(1):181. doi: 10.1186/s13046-021-01992-w.

Xue Zhang^{1

2}, Qiao-Li Lv^{1

2}, Yuan-Tao Huang^{1

2

3}, Li-Hua Zhang^{1

2}, Hong-Hao Zhou^{4

5}

¹ Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, People's Republic of China.
² Hunan Key Laboratory of Pharmacogenetics, Institute of Clinical Pharmacology, Central South University, Changsha, 410078, Hunan, People's Republic of China.
³ Department of Neurology, The Brain Hospital of Hunan Province, Changsha, 410007, Hunan, People's Republic of China.
⁴ Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, People's Republic of China. hhzhou2003@163.com.
⁵ Hunan Key Laboratory of Pharmacogenetics, Institute of Clinical Pharmacology, Central South University, Changsha, 410078, Hunan, People's Republic of China. hhzhou2003@163.com.

No abstract available

Publication types